Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion type Assertion NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_head.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion description "[To study the potential contribution of cellular PLSCR1 to the antiproliferative and tumor-suppressive activities of IFN, PLSCR1 cDNA was stably expressed in the human ovarian cancer cell line HEY1B, and the growth of these cells was compared with matched vector transfected controls both in vitro and in vivo.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_provenance.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion evidence source_evidence_literature NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_provenance.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion SIO_000772 11809687 NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_provenance.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion wasDerivedFrom befree-2016 NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_provenance.
- NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_assertion wasGeneratedBy ECO_0000203 NP343132.RAljAVDO583vpRg7BVdvYDJa2KWPJ_AbPhYB295W1wVc0130_provenance.